Cisatracurio Hikma recall in Canada: packaging differences
In plain language
This recall involves Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules imported into Canada. It's being recalled because the packaging differs from Canadian products and lacks a "PARALYZING AGENT" warning, which could lead to medication errors. Healthcare professionals should be aware of these differences to prevent patient harm.
What to do
- Stop using the product immediately.
- Check model/serial numbers if provided.
- Return, repair, or dispose of it as instructed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Cisatracurio Hikma 2 mg/mL Solution for injection/infusion
Model: AIC 044195093
Why this matters
Risk of medication error due to packaging differences
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: AIC 044195093
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of medication error due to packaging differences
What should consumers do?
Stop using the product immediately. Check model/serial numbers if provided. Return, repair, or dispose of it as instructed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of medication error due to packaging differences
When was this product recalled?
This product was recalled on April 24, 2024.
Is the Cisatracurio Hikma brand affected by this recall?
Yes, Cisatracurio Hikma products are affected by this recall. This recall involves Italian-authorized Cisatracurio Hikma 2 mg/mL Ampoules imported into Canada. It's being recalled because the packaging differs from Canadian products and lacks a "PARALYZING AGENT" warning, which could lead to medication errors. Healthcare professionals should be aware of these differences to prevent patient harm.